A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder
Author:
Publisher
Elsevier BV
Subject
Psychiatry and Mental health,Clinical Psychology
Reference17 articles.
1. Dysthymia: clinical and external validity;Akiskal;Acta Psychiatr. Scand.,1994
2. Dysthymia and the Spectrum of Chronic Depressions;Akiskal,1997
3. Diagnostic and Statistical Manual of Mental Disorders,1994
4. Amisulpiride versus amineptine and placebo for the treatment of dysthymia;Boyer;Neuropsychobiology,1999
5. Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas;Brunello;J. Affect. Disord.,1999
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Challenges in the treatment of dysthymia: a narrative review;Expert Review of Neurotherapeutics;2024-05-28
2. Examination of the mechanisms underlying the discriminative stimulus properties of the atypical antipsychotic amisulpride;Behavioural Pharmacology;2023-11-16
3. Adaptation and preliminary validation of the Montgomery-Åsberg Depression Rating Scale (MADRS) using the Structured Interview Guide (SIGMA) for European Portuguese;Psychologica;2023-10-02
4. A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatients;BMC Psychiatry;2023-07-28
5. Different symptomatic improvement pattern revealed by factor analysis between placebo response and response to Esketamine in treatment resistant depression;Psychiatry and Clinical Neurosciences;2022-06-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3